Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment
- 1 June 2017
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 27 (6) , 589-598
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Norway, Norway (223273)
- K.G. Jebsen Foundation, Norway
- Helse Sør-Øst RHF, Norway (2010074)
- Helse Vest RHF, Norway (911358)
- Dr. Einar Martens Reseach Foundation
- European Community׳s Seventh Framework Programme (FP7/2007-2013)
This publication has 82 references indexed in Scilit:
- Oligodendroglia metabolically support axons and contribute to neurodegenerationNature, 2012
- Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in ratPsychopharmacology, 2011
- MicroRNAs in lipid metabolismCurrent Opinion in Lipidology, 2011
- Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*Journal of Biological Chemistry, 2010
- miR-33 links SREBP-2 induction to repression of sterol transportersProceedings of the National Academy of Sciences, 2010
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based studyThe Lancet, 2009
- Large recurrent microdeletions associated with schizophreniaNature, 2008
- Differential effects of typical and atypical antipsychotics on brain myelination in schizophreniaSchizophrenia Research, 2007
- Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medicationsSchizophrenia Research, 2007
- Protein Sensors for Membrane SterolsCell, 2006